Eric K. Rowinsky - 01 Jan 2023 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Reporting relationship: Director
Issuer ticker: FBIO
Reported as of: 01 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jan 2023, 20:26:27 UTC
Prior SEC filing: 24 Jun 2022
Next SEC filing: 14 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Samuel Berry, Attorney-in-Fact

Key filing fact

Eric K. Rowinsky filed Form 4 for Fortress Biotech, Inc. (FBIO) on 04 Jan 2023.

Key facts

This page summarizes Eric K. Rowinsky's Form 4 filing for Fortress Biotech, Inc. (FBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Jan 2023, 20:26.

Change

Previous filing in this sequence was filed on 24 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FBIO transaction

COMMON STOCK, PAR VALUE $0.001

Award

Transaction value: $0
Shares: +100,000
Change %: +12%
Price: $0.000000
Shares after: 920,000
Date: 01 Jan 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

One-third of the shares will vest on each of January1, 2024, 2025 and 2026, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the reporting person's termination of service, or earlier upon his death or change in control of the Issuer.

Footnote F2

The total holdings include 200,000 shares of deferred restricted stock.